Alzheimer's disease is the most common form of dementia and is a significant burden for
affected patients, carers, and health systems. Great advances have been made in …

Purpose The complexities of pathological changes in Alzheimer's disease (AD) and their
relationships with associated risk factors and clinical symptoms, and the development of …

Recent progress in molecular imaging has provided new important knowledge for further
understanding the time course of early pathological disease processes in Alzheimer's …

Alzheimer's disease is a complex neurodegenerative disease affecting millions of
individuals worldwide. Earlier it was diagnosed only via clinical assessments and confirmed …

Alzheimer's disease (AD) is a devastating and progressive neurodegenerative disease for
which there is no cure. Mild cognitive impairment (MCI) is considered a prodromal stage of …

Currently, over five million Americans suffer with Alzheimer's disease (AD). In the absence of
a cure, this number could increase to 13.8 million by 2050. A critical goal of biomedical …

Abstract Alzheimer's disease (AD), a progressive neurodegenerative disease which
seriously endangers the health of the aged, is the most common etiology of senile dementia …

The increasing prevalence of dementia worldwide places a high demand on healthcare
providers to perform a diagnostic work-up in relatively early stages of the disease, given that …

PET is a non-invasive imaging technique which allows the visualization and quantification of
molecular processes, offering sensitive and early disease detection. Alzheimer's disease …

Alzheimer's disease (AD) has been reconceptualised as a dynamic pathophysiological
process characterized by preclinical, mild cognitive impairment (MCI), and dementia stages …